|
|
Volumn 7, Issue 5, 1998, Pages 729-740
|
|
Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists
|
|
Author keywords
Aquaretics; Congestive heart failure; Dysmenorrhea; Hyponatraemia; Liver cirrhosis; Non peptide compounds; Receptor antagonists; Receptors; SIADH; Vasopressin
|
|
Indexed keywords
1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE;
CONIVAPTAN;
CORTICOTROPIN;
CORTICOTROPIN RELEASING FACTOR;
GUANINE NUCLEOTIDE BINDING PROTEIN;
MOZAVAPTAN;
N TERT BUTYL 4 [5' ETHOXY 4 (2 MORPHOLINOETHOXY) 2' OXOSPIRO[CYCLOHEXANE 1,3' INDOLE] 1' SULFONYL] 3 METHOXYBENZAMIDE;
OXYTOCIN;
OXYTOCIN RECEPTOR;
UNCLASSIFIED DRUG;
VASOPRESSIN;
VASOPRESSIN RECEPTOR;
VASOPRESSIN RECEPTOR ANTAGONIST;
CONGESTIVE HEART FAILURE;
DRUG INDICATION;
DRUG RECEPTOR BINDING;
HUMAN;
HYPERTENSION;
HYPONATREMIA;
HYPOPHYSIS;
INAPPROPRIATE VASOPRESSIN SECRETION;
LIVER CIRRHOSIS;
NEPHROTIC SYNDROME;
REVIEW;
SIGNAL TRANSDUCTION;
VASCULAR SMOOTH MUSCLE;
WATER METABOLISM;
|
|
EID: 0031922116
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.7.5.729 Document Type: Review |
|
Times cited : (15)
|
|
References (74)
|
